Search Videos and More
Transforming Cancer Care and Delivery
The new President and CEO of Fox Chase Cancer CenterA $1.4 Million Grant Looks at Prostate Cancer Through a ‘Neighborhood Lens.’
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.Research on Making Cancer “Catch” the Flu Wins International Acclaim in Nature
Turning a "cold" tumor "hot" to fight advanced melanoma.Robotic Bronchoscopy
Each year, more lung cancer patients die from their disease than prostate, breast and colon cancer patients combined, making it the leading cause of deaths worldwide.For Recurrent Gyn Cancer, Immunotherapy is Becoming a Powerful Treatment Option
Gynecologic cancers that recur are typically treated as chronic diseases. Increasingly, oncologists at Fox Chase Cancer Center are turning to immunotherapy as a powerful option for chronic endometrial, cervical, and ovarian cancer management.Fertility-sparing Surgeries for Gynecologic Cancer
Fertility preservation is a top concern for many women of childbearing age who are diagnosed with gynecologic cancer. To make optimal treatment decisions that also allow the potential for future pregnancy, patients should take the time to consult with specialists.Sentinel Lymph Node Biopsy: Precision Diagnostics for Gynecologic Cancers
A sentinel lymph node biopsy (SLNB) can offer more effective treatment outcomes and improved quality of life for patients with gynecologic cancers.21st Annual Highlights of the 2022 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this virtual CME is designed to help medical, radiation, and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2022 San Antonio Breast Cancer Symposium into practice.What is the Same and What Has Changed with the Artificial Urinary Sphincter?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.Fox Chase Researchers Examine Racial Differences in Treatment and Outcomes of First-Line Therapies for Kidney Cancer
Digging into the "why" of racial disparity in kidney cancer outcomes.